Key clinical point: The GestAssured Test Kit looks promising as a predictor of preeclampsia.
Major finding: The test had 84% sensitivity, 77% specificity, and 93% negative predictive value, compared with adjudicated diagnoses.
Study details: Evaluation of a rapid urine test for preeclampsia in 329 samples from a prospective cohort.
Disclosures: This study was funded by GestVision and Saving Lives at Birth. Ms. Davis is an employee and shareholder of GestVision and is named as an inventor or coinventor on patents licensed for commercialization to the company.
REPORTING FROM ACOG 2019